Sabry, M;
Lowdell, MW;
(2013)
Tumor-Primed NK Cells: Waiting for the Green Light.
Front Immunol
, 4
, Article 408. 10.3389/fimmu.2013.00408.
![[thumbnail of fimmu-04-00408.pdf]](https://discovery.ucl.ac.uk/style/images/fileicons/application_pdf.png) Preview |
PDF
fimmu-04-00408.pdf Download (857kB) |
Abstract
The functional impairment of natural killer (NK) cells has been frequently reported in cancer studies. As one of the central components of host anti-tumor immunity, NK cells exert cellular cytotoxicity against tumor cells, and secrete a cytokine milieu to inhibit tumor progression and enable the recruitment of other immune cells to the tumor site. The unlocking of the full functional potential of NK cells requires successful progression through discrete activation stages that are tightly regulated by a complex array of signaling molecules. Target cell susceptibility to NK cell-mediated killing is dependent on the intensity and specific combination of ligand expression for NK cell receptors. Tumor cells utilize numerous strategies for evading NK cells, including the downregulation of important NK cell-activating ligands. Here, we review key studies on NK cell activation requirements, and argue, based on our findings from NK cell-tumor interactions, that the altered characteristics of tumor-associated NK cells are indicative of unmet signaling requirements for full NK cell activation, rather than NK cell dysfunction in cancer.
| Type: | Article |
|---|---|
| Title: | Tumor-Primed NK Cells: Waiting for the Green Light. |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.3389/fimmu.2013.00408 |
| Publisher version: | http://dx.doi.org/10.3389/fimmu.2013.00408 |
| Additional information: | © 2013 Sabry and Lowdell. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| Keywords: | CTV-1, LFA-1, NK cell dysfunction, NKG2D, cancer immunotherapy, natural killer cells |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1425551 |
Archive Staff Only
 |
View Item |
